Literature DB >> 21044774

High normal fasting blood glucose is associated with dementia in Chinese elderly.

James A Mortimer1, Amy R Borenstein, Ding Ding, Charles Decarli, Qianhua Zhao, Cathleen Copenhaver, Qihao Guo, Shugang Chu, Douglas Galasko, David P Salmon, Qi Dai, Yougui Wu, Ronald Petersen, Zhen Hong.   

Abstract

BACKGROUND: Diabetes is a risk factor for mild cognitive impairment (MCI) and dementia. However, the association between high normal fasting blood glucose (FBG) and dementia has not been studied.
METHODS: Polytomous logistic regression was used to assess the association of dementia and MCI with FBG in an age- and sex-matched sample of 32 dementia patients, 27 amnestic MCI (aMCI) patients, and 31 normal controls (NC). Analyses were repeated for those with normal FBG. Correlations between FBG and cognitive test scores were obtained.
RESULTS: Controlling for age, gender, education, body mass index, Hachinski Ischemic Score, magnetic resonance imaging (MRI) stroke, and normalized brain, hippocampal, and white matter hyperintensity MRI volumes; higher FBG was associated with dementia versus aMCI status (OR = 3.13; 95% CI, 1.28-7.69). This association remained (OR = 7.75; 95% CI, 1.10-55.56) when analyses were restricted to subjects with normal FBG. When dementia patients were compared with NC adjusting for age, gender, and education, a significant association with FBG also was seen (OR = 1.83; 95% CI, 1.09-3.08), but it was lost when vascular covariates were added to the model. FBG was not associated with aMCI status versus NC. Higher FBG was correlated with poorer performance on the Trailmaking Test Part B (P = .003). The percentage of dementia patients with high normal FBG (90%) was significantly higher than that of aMCI patients with high normal FBG (32.9%) (χ(2) = 13.9, P < .001).
CONCLUSIONS: Higher FBG was associated with dementia (vs. aMCI) independent of vascular risk factors and MRI indicators of vascular disease, and remained a significant risk factor when analyses were restricted to subjects with normal FBG. The results of this cross-sectional study suggest that a high normal level of FBG may be a risk factor for dementia.
Copyright © 2010 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21044774      PMCID: PMC2993007          DOI: 10.1016/j.jalz.2010.03.017

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  41 in total

1.  Direct electrochemical determination of glucose oxidase in biological samples.

Authors:  A Aubrée-Lecat; C Hervagault; A Delacour; P Beaude; C Bourdillon; M H Remy
Journal:  Anal Biochem       Date:  1989-05-01       Impact factor: 3.365

2.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.

Authors:  Rita Peila; Beatriz L Rodriguez; Lenore J Launer
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

3.  Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.

Authors:  J A Luchsinger; M X Tang; Y Stern; S Shea; R Mayeux
Journal:  Am J Epidemiol       Date:  2001-10-01       Impact factor: 4.897

4.  Aging, vascular risk, and cognition: blood glucose, pulse pressure, and cognitive performance in healthy adults.

Authors:  Cheryl L Dahle; Bradley S Jacobs; Naftali Raz
Journal:  Psychol Aging       Date:  2009-03

5.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

6.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

7.  Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort.

Authors:  Alka M Kanaya; Elizabeth Barrett-Connor; Ginny Gildengorin; Kristine Yaffe
Journal:  Arch Intern Med       Date:  2004-06-28

8.  Impact of diabetes on cognitive function among older Latinos: a population-based cohort study.

Authors:  Jasmanda H Wu; Mary N Haan; Jersey Liang; Debashis Ghosh; Hector M Gonzalez; William H Herman
Journal:  J Clin Epidemiol       Date:  2003-07       Impact factor: 6.437

9.  Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study.

Authors:  Reinhold Schmidt; Lenore J Launer; Lars-Göran Nilsson; Andrzej Pajak; Susanna Sans; Klaus Berger; Monique M Breteler; Maria de Ridder; Carole Dufouil; Rebecca Fuhrer; Simona Giampaoli; Albert Hofman
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

10.  Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years.

Authors:  Giancarlo Logroscino; Jae Hee Kang; Francine Grodstein
Journal:  BMJ       Date:  2004-02-23
View more
  4 in total

1.  Association between the characteristics of metabolic syndrome and Alzheimer's disease.

Authors:  Hui-Ting Yang; Yi-Jing Sheen; Chuen-Der Kao; Chin-An Chang; Ya-Chun Hu; Jiann-Liang Lin
Journal:  Metab Brain Dis       Date:  2013-05-04       Impact factor: 3.584

2.  Diabetes Mellitus is Associated with More Severe Brain Spontaneous Activity Impairment and Gray Matter Loss in Patients with Cirrhosis.

Authors:  Yun Fei Wang; Xiang Kong; Guang Ming Lu; Long Jiang Zhang
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

3.  The association between Western and Prudent dietary patterns and fasting blood glucose levels in type 2 diabetes and normal glucose metabolism in older Australian adults.

Authors:  Erin I Walsh; Felice N Jacka; Peter Butterworth; Kaarin J Anstey; Nicolas Cherbuin
Journal:  Heliyon       Date:  2017-06-07

4.  Cognitive decline is related to high blood glucose levels in older Chinese adults with the ApoE ε3/ε3 genotype.

Authors:  Qi Qiu; Xiang Lin; Lin Sun; Min-Jie Zhu; Tao Wang; Jing-Hua Wang; Guan-Jun Li; Shi-Fu Xiao; Xia Li
Journal:  Transl Neurodegener       Date:  2019-04-03       Impact factor: 8.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.